Hosford D

General

Full name : Hosford David

First name : David

Mail : Division of Neurology Products FDA10903 New Hampshire Ave.\/ Silver Spring, MD 20993

Zip Code :

City :

Country : USA

Email :

Phone :

Fax :

Website :

Directory :

Comment

References (4)

Title : AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit\/Hyperactivity Disorder in Adults - Potter_2014_Biol.Psychiatry_75_207
Author(s) : Potter AS , Dunbar GC , Mazzulla E , Hosford D , Newhouse PA
Ref : Biological Psychiatry , 75 :207 , 2014
Abstract :
PubMedSearch : Potter_2014_Biol.Psychiatry_75_207
PubMedID: 23856296

Title : Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant - Vieta_2014_Eur.Neuropsychopharmacol_24_564
Author(s) : Vieta E , Thase ME , Naber D , D'Souza B , Rancans E , Lepola U , Olausson B , Szamosi J , Wilson E , Hosford D , Dunbar G , Tummala R , Eriksson H
Ref : European Neuropsychopharmacology , 24 :564 , 2014
Abstract :
PubMedSearch : Vieta_2014_Eur.Neuropsychopharmacol_24_564
PubMedID: 24507016

Title : Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study - Kasperaviciute_2010_Brain_133_2136
Author(s) : Kasperaviciute D , Catarino CB , Heinzen EL , Depondt C , Cavalleri GL , Caboclo LO , Tate SK , Jamnadas-Khoda J , Chinthapalli K , Clayton LM , Shianna KV , Radtke RA , Mikati MA , Gallentine WB , Husain AM , Alhusaini S , Leppert D , Middleton LT , Gibson RA , Johnson MR , Matthews PM , Hosford D , Heuser K , Amos L , Ortega M , Zumsteg D , Wieser HG , Steinhoff BJ , Kramer G , Hansen J , Dorn T , Kantanen AM , Gjerstad L , Peuralinna T , Hernandez DG , Eriksson KJ , Kalviainen RK , Doherty CP , Wood NW , Pandolfo M , Duncan JS , Sander JW , Delanty N , Goldstein DB , Sisodiya SM
Ref : Brain , 133 :2136 , 2010
Abstract :
PubMedSearch : Kasperaviciute_2010_Brain_133_2136
PubMedID: 20522523

Title : The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone - Akuffo_2008_Biomarkers_13_618
Author(s) : Akuffo EL , Davis JB , Fox SM , Gloger IS , Hosford D , Kinsey EE , Jones NA , Nock CM , Roses AD , Saunders AM , Skehel JM , Smith MA , Cutler P
Ref : Biomarkers , 13 :618 , 2008
Abstract :
PubMedSearch : Akuffo_2008_Biomarkers_13_618
PubMedID: 18830857